# GridAI Technologies Corp.: financial statements, quarterly

GRDX · Nasdaq · CIK 1604191 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/grdx.md) · [Financials](/companies/grdx/financials.md) · [Filings](/companies/grdx/filings.md) · [Insiders](/companies/grdx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/grdx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001104659-26-066519.md) | [0.1](/filings/0001104659-26-108635.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.7](/filings/0001104659-26-066519.md) | [0.1](/filings/0001104659-26-108635.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [(0.6)](/filings/0001104659-26-066519.md) | [(0.0)](/filings/0001104659-26-108635.md) |
| Research and development | $m | [1.0](/filings/0001410578-24-001914.md) | [1.3 d](/filings/0001410578-25-000673.md) | [0.6](/filings/0001410578-25-001311.md) | [0.2](/filings/0001410578-25-001790.md) | [0.2](/filings/0001104659-25-114181.md) | [0.0 d](/filings/0001104659-26-054106.md) | [0.0](/filings/0001104659-26-066519.md) | [0.0](/filings/0001104659-26-108635.md) | [0.0](/filings/0001104659-25-114181.md) | [0.9 d](/filings/0001104659-26-054106.md) | [0.6](/filings/0001104659-26-066519.md) | [0.0](/filings/0001104659-26-108635.md) |
| Operating income | $m | [(3.4)](/filings/0001410578-24-001914.md) | [(4.1) d](/filings/0001410578-25-000673.md) | [(9.1)](/filings/0001410578-25-001311.md) | [(3.4)](/filings/0001410578-25-001790.md) | [(1.9)](/filings/0001104659-25-114181.md) | [(1.2) d](/filings/0001104659-26-054106.md) | [(0.8)](/filings/0001104659-26-066519.md) | [(0.6)](/filings/0001104659-26-108635.md) | [(0.9)](/filings/0001104659-25-114181.md) | [(4.7) d](/filings/0001104659-26-054106.md) | [(3.6)](/filings/0001104659-26-066519.md) | [(13.1)](/filings/0001104659-26-108635.md) |
| Interest expense | $m | [0.0](/filings/0001410578-23-002410.md) | [0.0 d](/filings/0001410578-24-000364.md) | [0.1](/filings/0001410578-24-000826.md) | [(0.0)](/filings/0001410578-24-001685.md) | [(0.0)](/filings/0001410578-24-001914.md) | not reported | [0.0](/filings/0001410578-25-001311.md) | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | [(14.9)](/filings/0001410578-25-001311.md) | [4.3](/filings/0001410578-25-001790.md) | [0.0 d](/filings/0001104659-25-114181.md) | not reported | not reported | [0.0](/filings/0001104659-26-108635.md) | not reported | not reported | [(0.3)](/filings/0001104659-26-066519.md) | [(0.1)](/filings/0001104659-26-108635.md) |
| Net income | $m | [(3.4)](/filings/0001410578-24-001914.md) | [(4.1) d](/filings/0001410578-25-000673.md) | [5.6](/filings/0001410578-25-001311.md) | [(8.8)](/filings/0001410578-25-001790.md) | [(2.6)](/filings/0001104659-25-114181.md) | [(12.2) d](/filings/0001104659-26-054106.md) | [(1.3)](/filings/0001410578-25-001311.md) | [(1.0)](/filings/0001410578-25-001790.md) | [(1.2)](/filings/0001104659-25-114181.md) | [(3.0) d](/filings/0001104659-26-054106.md) | [(3.4)](/filings/0001104659-26-066519.md) | [(13.0)](/filings/0001104659-26-108635.md) |
| Diluted EPS | $ per share | [(9.21)](/filings/0001410578-24-001914.md) | not reported | [0.38](/filings/0001410578-25-001311.md) | [(3.86)](/filings/0001410578-25-001790.md) | [(1.76)](/filings/0001104659-25-114181.md) | not reported | [(0.84)](/filings/0001104659-26-066519.md) | [(0.23)](/filings/0001104659-26-108635.md) | [(0.75)](/filings/0001104659-25-114181.md) | not reported | [(0.82)](/filings/0001104659-26-066519.md) | [(2.01)](/filings/0001104659-26-108635.md) |
| Basic EPS | $ per share | [(9.21)](/filings/0001410578-24-001914.md) | not reported | [3.12](/filings/0001410578-25-001311.md) | [(3.86)](/filings/0001410578-25-001790.md) | [(1.76)](/filings/0001104659-25-114181.md) | not reported | [(0.84)](/filings/0001104659-26-066519.md) | [(0.23)](/filings/0001104659-26-108635.md) | [(0.75)](/filings/0001104659-25-114181.md) | not reported | [(0.82)](/filings/0001104659-26-066519.md) | [(2.01)](/filings/0001104659-26-108635.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.3](/filings/0001410578-23-002410.md) | [3.7](/filings/0001410578-25-000673.md) | [3.4](/filings/0001410578-24-000826.md) | [0.7](/filings/0001410578-24-001685.md) | [0.4](/filings/0001410578-24-001914.md) | [0.2](/filings/0001104659-26-054106.md) | [0.1](/filings/0001410578-25-001311.md) | [0.0](/filings/0001104659-26-108635.md) | [2.5](/filings/0001104659-25-114181.md) | [0.9](/filings/0001104659-26-108635.md) | [0.4](/filings/0001104659-26-066519.md) | [1.4](/filings/0001104659-26-108635.md) |
| Current assets | $m | [4.0](/filings/0001410578-23-002410.md) | [5.0](/filings/0001410578-25-000673.md) | [7.5](/filings/0001410578-24-000826.md) | [84.4](/filings/0001410578-24-001685.md) | [83.8](/filings/0001410578-24-001914.md) | [83.5](/filings/0001104659-26-054106.md) | [83.5](/filings/0001410578-25-001311.md) | [83.3](/filings/0001410578-25-001790.md) | [87.7](/filings/0001104659-25-114181.md) | [2.6](/filings/0001104659-26-108635.md) | [2.6](/filings/0001104659-26-066519.md) | [2.3](/filings/0001104659-26-108635.md) |
| Total assets | $m | [5.9](/filings/0001410578-23-002410.md) | [6.9](/filings/0001410578-25-000673.md) | [91.1](/filings/0001410578-24-000826.md) | [86.3](/filings/0001410578-24-001685.md) | [85.8](/filings/0001410578-24-001914.md) | [85.4](/filings/0001104659-26-054106.md) | [85.2](/filings/0001410578-25-001311.md) | [85.1](/filings/0001410578-25-001790.md) | [135](/filings/0001104659-25-114181.md) | [48.6](/filings/0001104659-26-108635.md) | [48.0](/filings/0001104659-26-066519.md) | [37.0](/filings/0001104659-26-108635.md) |
| Current liabilities | $m | [2.5](/filings/0001410578-23-002410.md) | [3.1](/filings/0001410578-25-000673.md) | [6.2](/filings/0001410578-24-000826.md) | [15.4](/filings/0001410578-24-001685.md) | [15.7](/filings/0001410578-24-001914.md) | [27.5](/filings/0001104659-26-054106.md) | [28.7](/filings/0001410578-25-001311.md) | [29.7](/filings/0001410578-25-001790.md) | [33.5](/filings/0001104659-25-114181.md) | [15.2](/filings/0001104659-26-108635.md) | [16.2](/filings/0001104659-26-066519.md) | [14.1](/filings/0001104659-26-108635.md) |
| Total liabilities | $m | [2.6](/filings/0001410578-23-002410.md) | [3.3](/filings/0001410578-25-000673.md) | [13.3](/filings/0001410578-24-000826.md) | [15.5](/filings/0001410578-24-001685.md) | [15.8](/filings/0001410578-24-001914.md) | [27.6](/filings/0001104659-26-054106.md) | [28.7](/filings/0001410578-25-001311.md) | [29.7](/filings/0001410578-25-001790.md) | [45.8](/filings/0001104659-25-114181.md) | [19.7](/filings/0001104659-26-108635.md) | [20.5](/filings/0001104659-26-066519.md) | [18.3](/filings/0001104659-26-108635.md) |
| Long-term debt | $m | not reported | not reported | [6.4](/filings/0001410578-24-000826.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | [0.4](/filings/0001410578-24-000826.md) | [0.2](/filings/0001410578-24-001685.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [3.3](/filings/0001410578-24-001914.md) | [3.6](/filings/0001410578-25-001790.md) | [16.2](/filings/0001410578-25-001790.md) | [9.1](/filings/0001410578-25-001790.md) | [8.4](/filings/0001410578-24-001914.md) | [(3.9)](/filings/0001410578-25-001790.md) | [(5.2)](/filings/0001410578-25-001790.md) | [(6.3)](/filings/0001410578-25-001790.md) | [27.9](/filings/0001104659-25-114181.md) | [24.9](/filings/0001104659-26-108635.md) | [23.6](/filings/0001104659-26-108635.md) | [14.9](/filings/0001104659-26-108635.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(3,331) d](/filings/0001410578-24-001914.md) | [(3,439) d](/filings/0001410578-25-000673.md) | [(3,747)](/filings/0001410578-25-001311.md) | [(3,451) d](/filings/0001410578-25-001790.md) | [(1,848) d](/filings/0001104659-25-114181.md) | [(172) d](/filings/0001104659-26-054106.md) | [(819)](/filings/0001104659-26-066519.md) | [(54.9) d](/filings/0001104659-26-108635.md) | [(856) d](/filings/0001104659-25-114181.md) | [(3,974) d](/filings/0001104659-26-054106.md) | [(1,787)](/filings/0001104659-26-066519.md) | [(1,505) d](/filings/0001104659-26-108635.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.1](/filings/0001410578-23-001882.md) | [0.2](/filings/0001410578-23-002410.md) | [0.1](/filings/0001410578-24-000826.md) | [0.1](/filings/0001410578-24-001685.md) | [0.4](/filings/0001410578-24-001914.md) | [14.5](/filings/0001410578-25-001311.md) | [2.3](/filings/0001410578-25-001790.md) | [1.5](/filings/0001104659-25-114181.md) | [4.8](/filings/0001104659-26-108635.md) | [1.7](/filings/0001104659-25-114181.md) | [4.5](/filings/0001104659-26-066519.md) | [6.4](/filings/0001104659-26-108635.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,131,123 at 2026-08-21, from the cover of the [10-Q/A filed 2026-09-18](/filings/0001104659-26-108635.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.